34-20B-20.2. Xylazine--Permissible uses.
131 words·~1 min read·
/sd/title-34/chapter-34-20/34-20b-20-2·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(1)Dispensing, prescribing, or administering, to an animal, a drug containing xylazine that has been approved by the United States secretary of health and human services under 21 U.S.C. § 360b (January 1, 2024);
(2)Dispensing, prescribing, or administering xylazine to an animal that is permissible under 21 U.S.C. § 360b(a)(4) (January 1, 2024);
(3)Manufacturing, distributing, or using xylazine as an active pharmaceutical ingredient for manufacturing an animal drug:
(a)Approved under 21 U.S.C. § 360b (January 1, 2024); or
(b)Issued an investigation use exemption under 21 U.S.C. § 360b(j) (January 1, 2024);
(4)Manufacturing, distributing, or using a xylazine bulk chemical for pharmaceutical compounding by a licensed pharmacist or veterinarian; or
(5)Any other use approved or permissible under 21 U.S.C. § 301, et seq. (January 1, 2024).